These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2979055)

  • 1. Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
    Smyth MJ; Pietersz GA; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():123-56. PubMed ID: 2979055
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of anthracycline-antibody complexes for specific antitumor activity.
    Pietersz GA; Smyth MJ; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():25-53. PubMed ID: 2979059
    [No Abstract]   [Full Text] [Related]  

  • 3. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
    Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
    Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biodistribution of monoclonal antibody and Fab fragment and antitumor effect of their conjugates on hepatoma xenografts].
    Li J; Zhen Y; Yang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Oct; 16(5):328-33. PubMed ID: 7720121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and testing of antibody-antifolate conjugates for drug targeting.
    Ghose T; Blair AH; Kralovec J; Mammen M; Uadia PO
    Targeted Diagn Ther; 1988; 1():81-122. PubMed ID: 2979064
    [No Abstract]   [Full Text] [Related]  

  • 6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies as carriers of toxins.
    Uhr JW; Fulton RJ; Till MA; May RD; Vitetta ES
    Prog Clin Biol Res; 1989; 288():403-12. PubMed ID: 2785694
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
    Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunotoxin against human glioma cells.
    Manome Y; Watanabe M; Ohno T
    Neurochirurgia (Stuttg); 1989 Sep; 32(5):146-9. PubMed ID: 2797358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect of the immunoconjugate composed of antibiotic C1027 and Fab fragment from a monoclonal antibody directed against human hepatoma].
    Li JZ; Jiang M; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1993; 28(4):260-5. PubMed ID: 8213168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of chimeric Fab fragments of monoclonal antibody A7 for targeting chemotherapy against pancreatic cancer].
    Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2285-7. PubMed ID: 9422075
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
    Vega MI; Huerta-Yepez S; Martinez-Paniagua M; Martinez-Miguel B; Hernandez-Pando R; González-Bonilla CR; Chinn P; Hanna N; Hariharan K; Jazirehi AR; Bonavida B
    Clin Cancer Res; 2009 Nov; 15(21):6582-94. PubMed ID: 19861448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human monoclonal antibody to carbohydrate moiety of carcinoembryonic antigen.
    Tsukazaki K; Kuroda K; Mochizuki K; Kubushiro K; Fukuchi T; Kato M; Hashizume S; Nozawa S
    Hum Antibodies Hybridomas; 1995; 6(4):145-52. PubMed ID: 8688497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapeutics and apoptosis.
    Ludwig DL; Pereira DS; Zhu Z; Hicklin DJ; Bohlen P
    Oncogene; 2003 Dec; 22(56):9097-106. PubMed ID: 14663488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.
    Steele JK; Liu D; Stammers AT; Deal H; Whitney S; Levy JG
    Targeted Diagn Ther; 1988; 1():157-89. PubMed ID: 2980947
    [No Abstract]   [Full Text] [Related]  

  • 20. A humanized single-chain Fv fragment with high targeting potential against human malignant gliomas.
    Ohtomo T; Kawata H; Sekimori Y; Shimizu K; Kishima H; Moriuchi S; Miyao Y; Akamatsu K; Tsuchiya M
    Anticancer Res; 1998; 18(6A):4311-5. PubMed ID: 9891484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.